Table 2.

Association of aortic wall thickness with cardiometabolic parameters

Parameter	Rho (P-value)
Demographic and Clinical Characteristics (n=165)	AWT
Age (years)	0.38 (<0.001)
Sex (male)	0.07 (0.37)
BMI (kg/m2)	0.17 (0.03)
Current smoker	−0.04 (0.61)
Hypertension	0.18 (0.02)
Diabetes	0.05 (0.49)
Hyperlipidemia	0.28 (<0.001)
Statin treatment	0.19 (0.02)
Hypertensive treatment	0.11 (0.15)
Diabetic treatment	0.04 (0.58)
Clinical and Lab Values
Systolic blood pressure (mm Hg)	0.21 (0.01)
Diastolic blood pressure (mm Hg)	0.17 (0.03)
HOMA-IR	0.08 (0.31)
Total cholesterol (mg/dL)	0.005 (0.96)
HDL cholesterol (mg/dL)	0.03 (0.74)
LDL cholesterol (mg/dL)	−0.01 (0.85)
Triglycerides (mg/dL)	0.04 (0.65)
Glycated hemoglobin (%)	0.08 (0.42)
C-reactive protein, mg/L	0.08 (0.31)
Framingham risk score	0.53 (<0.001)
Psoriasis Severity
PASI score	0.20 (0.01)
Disease duration, years	0.02 (0.78)
Systemic or biologic Treatment	−0.24 (0.003)
Vascular Characteristics
Aortic vascular uptake of FDG by PET/CT (TBR)	0.27 (0.001)

Values reported as standardized rho coefficient (p-value). BMI: Body Mass Index. HOMA-IR: Homeostatic Model Assessment for Insulin Resistance. HDL: High Density Lipoprotein. LDL: Low Density Lipoprotein. PASI: Psoriasis Area Severity Index. TBR: Target to background ratio.